Canada Life
ARVN icon

Canada Life’s Arvinas ARVN Stock Holding History

Canada Life’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Hold
5,092
– – ﹤0.01% 1764
2026
Q1 		$54K Hold
5,092
– – ﹤0.01% 1748
2025
Q4 		$60K Hold
5,092
– – ﹤0.01% 1771
2025
Q3 		$43K Hold
5,092
– – ﹤0.01% 1821
2025
Q2 		$38K Sell
5,092
-9,432
-65% -$69.5K ﹤0.01% 1846
2025
Q1 		$102K Hold
14,524
– – ﹤0.01% 1776
2024
Q4 		$278K Hold
14,524
– – ﹤0.01% 1714
2024
Q3 		$359K Hold
14,524
– – ﹤0.01% 1735
2024
Q2 		$386K Sell
14,524
-3,202
-18% -$102K ﹤0.01% 1729
2024
Q1 		$732K Sell
17,726
-2,691
-13% -$118K ﹤0.01% 1583
2023
Q4 		$835K Buy
20,417
+4,001
+24% +$93.5K ﹤0.01% 1557
2023
Q3 		$322K Buy
16,416
+2,784
+20% +$68.3K ﹤0.01% 1779
2023
Q2 		$340K Buy
13,632
+1,450
+12% +$37.3K ﹤0.01% 1765
2023
Q1 		$333K Sell
12,182
-24,142
-66% -$763K ﹤0.01% 1791
2022
Q4 		$1.25M Buy
36,324
+4,029
+12% +$170K ﹤0.01% 1442
2022
Q3 		$1.44M Sell
32,295
-3,721
-10% -$181K ﹤0.01% 1331
2022
Q2 		$1.51M Buy
36,016
+18,230
+102% +$915K ﹤0.01% 1289
2022
Q1 		$1.27M Buy
17,786
+15,678
+744% +$1.07M ﹤0.01% 1443
2021
Q4 		$172K Hold
2,108
– – ﹤0.01% 1896
2021
Q3 		$174K Hold
2,108
– – ﹤0.01% 1926
2021
Q2 		$162K Buy
2,108
+16
+0.8% +$1.11K ﹤0.01% 1974
2021
Q1 		$137K Buy
2,092
+836
+67% +$64K ﹤0.01% 2029
2020
Q4 		$106K Hold
1,256
– – ﹤0.01% 2099
2020
Q3 		$30K Hold
1,256
– – ﹤0.01% 2325
2020
Q2 		$42K Buy
1,256
+711
+130% +$30.2K ﹤0.01% 2269
2020
Q1 		$22K Hold
545
– – ﹤0.01% 2351
2019
Q4 		$22K Buy
+545
New +$16K ﹤0.01% 2474
2019
Q3 		– Sell
-1,028
Closed -$22K – 1193
2019
Q2 		$22K Buy
+1,028
New +$21.6K ﹤0.01% 2577

Other funds holding ARVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canada Life's ARVN Position: Q2 2026 in Review

Canada Life held its Arvinas (ARVN) position steady in Q2 2026 at 5,092 shares worth $42K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.

Canada Life first reported a position in ARVN in Q2 2019 and has held it in 28 quarters since. The position peaked at $1.51M in Q2 2022. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Canada Life held 5,092 shares of Arvinas worth $42K as of Q2 2026.
  • Canada Life left its Arvinas share count unchanged in Q2 2026.
  • Arvinas made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1764 holding.
  • Canada Life first reported a position in Arvinas in Q2 2019 and has held it in 28 quarters since.
  • Canada Life's Arvinas position peaked at $1.51M in Q2 2022.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.